Abt Associates
Recent developments reported by Abt Associates
Published in Hospital Business Week, February 25th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Abt Associates.
Report 1: An analysis of observational data from real-world clinical practice suggests Procrit (Epoetin alfa) has a lower drug cost in the outpatient setting when treating chemotherapy-induced anemia, compared with darbepoetin alfa, another drug in the same class.
Based on the average cumulative, administered doses per patient and wholesale acquisition cost (WAC), the study showed that the calculated drug cost for darbepoetin alfa was approximately 16% more than...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Allergy & Immunology
Pollinex Quattro grass dosing begins in first-ever global allergy vaccine trial - Ascites
Researchers at Hamad Medical Corporation, Department of Medicine have published new data on ascites - Birth Defects
Birth defect hospitalizations cost $2.6 billion annually - Brain Cancer Epidemiology
Research on brain cancer epidemiology detailed by scientists at Eli Lilly and Company - Business & Finance
Akers Bioscience reports 2006 revenues expected to be $5.2 million in fourth growth year - Business Update
Accenture prototype shows benefits of nationwide health information network - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
